Best VCs for Drug Discovery

37 venture capitalists actively investing in Drug Discovery.

37
Active VCs
0
Funds
0
Deals
#1Tess van Stekelenburg

Partner

Lux Capital

Tess is a technically trained generalist investing where AI, biology, aerospace, and the physical world intersect. She seeks engineers and scientists turning frontier research into companies, with par

No verified personal or standard Lux check-size range is published. Tess invests at both early and growth stages and participates in Lux company creation; founders should confirm round fit directly rather than infer an allocation from fund size or disclosed company rounds.
Company CreationSeedSeries A
#2Rachelle Young

Investor Relations Director

BioGeneration Ventures

The official roster identifies Rachelle Young as Investor Relations Director. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

BGV does not publish a standard current startup check-size range on its official site.
Company CreationSeedSeries A
#3Elisa Camorani

Senior Associate ESG and Impact

BioGeneration Ventures

The official roster identifies Elisa Camorani as Senior Associate ESG and Impact. This profile applies BioGeneration Ventures's published strategy and does not infer undisclosed personal signing autho

BGV does not publish a standard current startup check-size range on its official site.
Company CreationSeedSeries A
#4Cyril Lesser

Vice President Finance | Funds

BioGeneration Ventures

The official roster identifies Cyril Lesser as Vice President Finance | Funds. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

BGV does not publish a standard current startup check-size range on its official site.
Company CreationSeedSeries A
#5Arnoud Dijkstra

Venture Partner

BioGeneration Ventures

The official roster identifies Arnoud Dijkstra as Venture Partner. This profile applies BioGeneration Ventures's published strategy and does not infer undisclosed personal signing authority or a narro

BGV does not publish a standard current startup check-size range on its official site.
Company CreationSeedSeries A
#6Machteld Groeneveld

Chief Compliance Officer & Legal Affairs

BioGeneration Ventures

The official roster identifies Machteld Groeneveld as Chief Compliance Officer & Legal Affairs. This is a fund team or operating role; no direct investment mandate or personal signing authority is inf

BGV does not publish a standard current startup check-size range on its official site.
Company CreationSeedSeries A
#7Oskar Slotboom

Managing Partner

BioGeneration Ventures

The official roster identifies Oskar Slotboom as Managing Partner. This profile applies BioGeneration Ventures's published strategy and does not infer undisclosed personal signing authority or a narro

BGV does not publish a standard current startup check-size range on its official site.
Company CreationSeedSeries A
#8Daniela Couto

General Partner

BioGeneration Ventures

The official roster identifies Daniela Couto as General Partner. This profile applies BioGeneration Ventures's published strategy and does not infer undisclosed personal signing authority or a narrowe

BGV does not publish a standard current startup check-size range on its official site.
Company CreationSeedSeries A
#9Olga Ziessen

Manager Secretarial Services

BioGeneration Ventures

The official roster identifies Olga Ziessen as Manager Secretarial Services. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

BGV does not publish a standard current startup check-size range on its official site.
Company CreationSeedSeries A
#10Robbert van de Griendt

Head of Investor Relations

BioGeneration Ventures

The official roster identifies Robbert van de Griendt as Head of Investor Relations. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

BGV does not publish a standard current startup check-size range on its official site.
Company CreationSeedSeries A
#11Wouter Verhoeven

Venture Partner

BioGeneration Ventures

The official roster identifies Wouter Verhoeven as Venture Partner. This profile applies BioGeneration Ventures's published strategy and does not infer undisclosed personal signing authority or a narr

BGV does not publish a standard current startup check-size range on its official site.
Company CreationSeedSeries A
#12Rianne Ellenbroek

Principal

BioGeneration Ventures

The official roster identifies Rianne Ellenbroek as Principal. This profile applies BioGeneration Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower

BGV does not publish a standard current startup check-size range on its official site.
Company CreationSeedSeries A
#13John J.P. Kastelein

Senior Advisor

BioGeneration Ventures

The official roster identifies John J.P. Kastelein as Senior Advisor. This profile applies BioGeneration Ventures's published strategy and does not infer undisclosed personal signing authority or a na

BGV does not publish a standard current startup check-size range on its official site.
Company CreationSeedSeries A
#14Patricia Vonk

AML/KYC Manager

BioGeneration Ventures

The official roster identifies Patricia Vonk as AML/KYC Manager. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

BGV does not publish a standard current startup check-size range on its official site.
Company CreationSeedSeries A
#15Jennifer Fritzsche

Vice President Finance

BioGeneration Ventures

The official roster identifies Jennifer Fritzsche as Vice President Finance. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

BGV does not publish a standard current startup check-size range on its official site.
Company CreationSeedSeries A
#16Silva Dezelan

Head of Impact and ESG

BioGeneration Ventures

The official roster identifies Silva Dezelan as Head of Impact and ESG. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

BGV does not publish a standard current startup check-size range on its official site.
Company CreationSeedSeries A
#17Karen Chan

Associate

BioGeneration Ventures

The official roster identifies Karen Chan as Associate. This profile applies BioGeneration Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individ

BGV does not publish a standard current startup check-size range on its official site.
Company CreationSeedSeries A
#18Dragana Dragusin

Executive Assistant

BioGeneration Ventures

The official roster identifies Dragana Dragusin as Executive Assistant. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

BGV does not publish a standard current startup check-size range on its official site.
Company CreationSeedSeries A
#19Elena Ritsou

Venture Partner

BioGeneration Ventures

The official roster identifies Elena Ritsou as Venture Partner. This profile applies BioGeneration Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower

BGV does not publish a standard current startup check-size range on its official site.
Company CreationSeedSeries A
#20Maureen Wouters

Paralegal

BioGeneration Ventures

The official roster identifies Maureen Wouters as Paralegal. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

BGV does not publish a standard current startup check-size range on its official site.
Company CreationSeedSeries A
#21Rob de Ree

Venture Partner

BioGeneration Ventures

The official roster identifies Rob de Ree as Venture Partner. This profile applies BioGeneration Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower i

BGV does not publish a standard current startup check-size range on its official site.
Company CreationSeedSeries A
#22Christina Takke

Managing Partner

V-Bio Ventures

The official roster identifies Christina Takke as Managing Partner. This profile applies V-Bio Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower ind

V-Bio does not publish a standard current startup check-size range on its official site.
Company CreationEarly StageMid Stage
#23Katja Rosenkranz

Partner

V-Bio Ventures

The official roster identifies Katja Rosenkranz as Partner. This profile applies V-Bio Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual

V-Bio does not publish a standard current startup check-size range on its official site.
Company CreationEarly StageMid Stage
#24Martin Solleveld

Finance Manager

V-Bio Ventures

The official roster identifies Martin Solleveld as Finance Manager. This is a fund team or operating role; no direct investment mandate or personal signing authority is inferred.

V-Bio does not publish a standard current startup check-size range on its official site.
Company CreationEarly StageMid Stage
#25Mathias Falcenberg

Venture Partner

V-Bio Ventures

The official roster identifies Mathias Falcenberg as Venture Partner. This profile applies V-Bio Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower i

V-Bio does not publish a standard current startup check-size range on its official site.
Company CreationEarly StageMid Stage
#26Shelley Margetson

Managing Partner

V-Bio Ventures

The official roster identifies Shelley Margetson as Managing Partner. This profile applies V-Bio Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower i

V-Bio does not publish a standard current startup check-size range on its official site.
Company CreationEarly StageMid Stage
#27Ward Capoen

Partner

V-Bio Ventures

The official roster identifies Ward Capoen as Partner. This profile applies V-Bio Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual manda

V-Bio does not publish a standard current startup check-size range on its official site.
Company CreationEarly StageMid Stage
#28Willem Broekaert

Managing Partner

V-Bio Ventures

The official roster identifies Willem Broekaert as Managing Partner. This profile applies V-Bio Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower in

V-Bio does not publish a standard current startup check-size range on its official site.
Company CreationEarly StageMid Stage
#29Karel Kubias, MBA

Founding Partner

i&i Bio

Karel Kubias, MBA invests or supports investment decisions through i&i Bio's published strategy: Invest in scientifically strong early-stage life-science companies, with primary focus on Central and E

€150K for company creation and roughly €500K-€2M for initial venture investments, as published by i&i Bio.
Company CreationPre-SeedSeed
#30Ivan Vohlmuth

Founding Partner

i&i Bio

Ivan Vohlmuth invests or supports investment decisions through i&i Bio's published strategy: Invest in scientifically strong early-stage life-science companies, with primary focus on Central and Easte

€150K for company creation and roughly €500K-€2M for initial venture investments, as published by i&i Bio.
Company CreationPre-SeedSeed
#31Barbora Šumová, Ph.D.

Partner

i&i Bio

Barbora Šumová, Ph.D. invests or supports investment decisions through i&i Bio's published strategy: Invest in scientifically strong early-stage life-science companies, with primary focus on Central a

€150K for company creation and roughly €500K-€2M for initial venture investments, as published by i&i Bio.
Company CreationPre-SeedSeed
#32Tomáš Maršálek, MBA

Founding Partner

i&i Bio

Tomáš Maršálek, MBA invests or supports investment decisions through i&i Bio's published strategy: Invest in scientifically strong early-stage life-science companies, with primary focus on Central and

€150K for company creation and roughly €500K-€2M for initial venture investments, as published by i&i Bio.
Company CreationPre-SeedSeed
#33Dr. Anela Vukoja

Partner

i&i Bio

Dr. Anela Vukoja invests or supports investment decisions through i&i Bio's published strategy: Invest in scientifically strong early-stage life-science companies, with primary focus on Central and Ea

€150K for company creation and roughly €500K-€2M for initial venture investments, as published by i&i Bio.
Company CreationPre-SeedSeed
#34Magdalena Marciniak, Ph.D.

Advisor

i&i Bio

Magdalena Marciniak, Ph.D. is listed in a Advisor capacity at i&i Bio. The firm does not publish a person-specific investment mandate for this role; the firm's strategy is included only as shared orga

€150K for company creation and roughly €500K-€2M for initial venture investments, as published by i&i Bio.
Company CreationPre-SeedSeed
#35Pavlína Koutecká

Associate

i&i Bio

Pavlína Koutecká invests or supports investment decisions through i&i Bio's published strategy: Invest in scientifically strong early-stage life-science companies, with primary focus on Central and Ea

€150K for company creation and roughly €500K-€2M for initial venture investments, as published by i&i Bio.
Company CreationPre-SeedSeed
#36Simona Šandová

Office Manager

i&i Bio

Simona Šandová is listed in a Office Manager capacity at i&i Bio. The firm does not publish a person-specific investment mandate for this role; the firm's strategy is included only as shared organizat

€150K for company creation and roughly €500K-€2M for initial venture investments, as published by i&i Bio.
Company CreationPre-SeedSeed
#37Shaq Vayda

Partner

Lux Capital

Shaq partners with technical founders building instruments that make invisible physical or biological signals legible and platforms whose downstream value exceeds the value captured by the initial pro

Firm-level: Lux says it can invest from an initial $100K through high-conviction follow-ons as large as $100M across the company-building arc. This is not Shaq's personal standard check range.
InceptionPre-SeedSeed

Explore more sectors

All SectorsDrug Discovery InvestmentsAll VCs